Fortrea Holdings (FTRE) Net Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Net Margin came in at 1.95% in Q2 2026, up 5083.0% on a YoY basis from 0.04% in Q2 2025, and up 47.51% quarter-over-quarter from 3.71% in Q1 2026.
Powered by 
Analysis
Fortrea Holdings (FTRE) Net Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Net Margin for 5 consecutive years, with 1.95% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 5083.0% year-over-year to 1.95%; the trailing twelve-month figure through Jun 2026 stood at 3.18% (up 3438.0% YoY), and the FY2025 full-year result was 36.21%, down 2403.0% from the prior year.
- Net Margin grew to 1.95% in Q2 2026 per FTRE's latest filing, from 3.71% in the prior quarter.
- Across five years, Net Margin topped out at 8.37% in Q2 2022 and bottomed at 86.43% in Q1 2025.
- Historically, Net Margin has averaged 11.24% across 5 years, with a median of 3.71% in 2026.
- The sharpest annual moves came in 2025 and 2026: Net Margin sank 7117 bps in 2025, then soared 8272 bps in 2026.
- Over 5 years, Net Margin stood at 2.71% in 2022, then tumbled by 184 bps to 7.68% in 2023, then dropped by 14 bps to 8.78% in 2024, then soared by 44 bps to 4.92% in 2025, then soared by 60 bps to 1.95% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 1.95%, 3.71%, and 4.92% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 5.52% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 17.16% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | -0.08% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 9.61% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | -1.95% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -231.74% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -4.82% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -83.13% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -15,211.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.95% |
| Mar 31, 2026 | -3.71% |
| Dec 31, 2025 | -4.92% |
| Sep 30, 2025 | -2.27% |
| Jun 30, 2025 | -52.78% |
| Mar 31, 2025 | -86.43% |
| Dec 31, 2024 | -8.78% |
| Sep 30, 2024 | -4.13% |
| Jun 30, 2024 | -20.89% |
| Mar 31, 2024 | -15.25% |
| Dec 31, 2023 | -7.68% |
| Sep 30, 2023 | -1.96% |
| Jun 30, 2023 | 4.25% |
| Mar 31, 2023 | 1.80% |
| Dec 31, 2022 | -2.71% |
| Sep 30, 2022 | 7.95% |
| Jun 30, 2022 | 8.37% |